COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
作者：
TIDEFELT, U
SUNDMANENGBERG, B
PAUL, C
机构：
[1] HUDDINGE HOSP,DEPT MED,DIV CLIN HEMATOL & ONCOL,S-14146 HUDDINGE,SWEDEN
[2] KAROLINSKA INST,S-14186 HUDDINGE,SWEDEN
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 229
页数：5
相关论文
共 21 条
[1]  
ANDERSSON B, 1982, CANCER RES, V42, P178
[2]  
BAURAIN R, 1978, CURRENT CHEMOTHERAPY, V2, P1130
[3]   TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN [J].
BONFANTE, V ;
VILLANI, F ;
BONADONNA, G .
TUMORI JOURNAL, 1982, 68 (02) :105-111
[4]  
CAMAGGI CM, 1985, DRUG EXP CLIN RES, V11, P285
[5]  
CAMAGGI CM, 1982, CANCER TREAT REP, V66, P1819
[6]  
CASAZZA AM, 1980, ANTHRACYCLINES CURRE, P403
[7]   EPIRUBICIN - A REVIEW OF THE PHARMACOLOGY, CLINICAL ACTIVITY, AND ADVERSE-EFFECTS OF AN ADRIAMYCIN ANALOG [J].
CERSOSIMO, RJ ;
HONG, WK .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :425-439
[8]  
DAVIS HL, 1979, CANCER TREAT REP, V63, P809
[9]   CHANGES OF ACTIVITY OF DAUNORUBICIN, ADRIAMYCIN AND STEREOISOMERS FOLLOWING INTRODUCTION OR REMOVAL OF HYDROXYL-GROUPS IN AMINO SUGAR MOIETY [J].
DIMARCO, A ;
CASAZZA, AM ;
DASDIA, T ;
NECCO, A ;
PRATESI, G ;
RIVOLTA, P ;
VELCICH, A ;
ZACCARA, A ;
ZUNINO, F .
CHEMICO-BIOLOGICAL INTERACTIONS, 1977, 19 (03) :291-302
[10]   COMPARATIVE PHARMACOKINETIC STUDY OF ADRIAMYCIN AND 4'EPI-ADRIAMYCIN AFTER THEIR SIMULTANEOUS INTRAVENOUS ADMINISTRATION [J].
EKSBORG, S ;
STENDAHL, U ;
LONROTH, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (05) :629-631
123